BI-10773 (Empagliflozin) Combination Database

Jump to:

• BI-10773 (Empagliflozin) Mechanism of Action: SGLT2 Inhibition in Cardiomyocytes Research
• BI-10773 (Empagliflozin) Working Concentration | Cell Culture | Treatment
• BI-10773 (Empagliflozin) Solubility in DMSO
• BI-10773 (Empagliflozin) Storage & Stability
• BI-10773 (Empagliflozin) Molecular Weight | Chemical Structure | Stock Solution
• BI-10773 (Empagliflozin) IC50 for Cell-based and Cell-free Assays
• BI-10773 (Empagliflozin) Sigma (SML4200)? Try a better option.
• BI-10773 (Empagliflozin) MCE (HY-15409)? Try a better option.
• BI-10773 (Empagliflozin) Cayman (17375)? Try a better option.
• BI-10773 (Empagliflozin) APExBIO (A4601)? Try a better option.
• BI-10773 (Empagliflozin) Axonmedchem (Axon 3367)? Try a better option.
• BI-10773 (Empagliflozin) SDS｜MSDS
• BI-10773 (Empagliflozin) in Heart Failure
• BI-10773 (Empagliflozin) in Chronic Kidney Disease
• BI-10773 (Empagliflozin) in Non-alcoholic Fatty Liver Disease